The TheraCyte™ Device Protects against Islet Allograft Rejection in Immunized Hosts
Clinically, many candidates for islet transplantation are already immunized, which increases their risk of graft rejection. Encapsulation of pancreatic islets using the TheraCyte™ device has been shown to protect against allograft rejection in nonimmunized recipients. However, the capacity of the Th...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2013-07-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.3727/096368912X657486 |